254 related articles for article (PubMed ID: 8768927)
21. Immunoglobulin light (heavy)-chain deposition disease: from molecular medicine to pathophysiology-driven therapy.
Ronco P; Plaisier E; Mougenot B; Aucouturier P
Clin J Am Soc Nephrol; 2006 Nov; 1(6):1342-50. PubMed ID: 17699367
[TBL] [Abstract][Full Text] [Related]
22. Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis.
Nasr SH; Markowitz GS; Stokes MB; Seshan SV; Valderrama E; Appel GB; Aucouturier P; D'Agati VD
Kidney Int; 2004 Jan; 65(1):85-96. PubMed ID: 14675039
[TBL] [Abstract][Full Text] [Related]
23. Renal granular monoclonal light chain deposits: morphological aspects in 11 cases.
Noel LH; Droz D; Ganeval D; Grunfeld JP
Clin Nephrol; 1984 May; 21(5):263-9. PubMed ID: 6428790
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal immunoglobulin light and heavy chain deposition diseases: molecular models of common renal diseases.
Ronco P; Plaisier E; Aucouturier P
Contrib Nephrol; 2011; 169():221-231. PubMed ID: 21252522
[TBL] [Abstract][Full Text] [Related]
25. IgD heavy-chain deposition disease: detection by laser microdissection and mass spectrometry.
Royal V; Quint P; Leblanc M; LeBlanc R; Duncanson GF; Perrizo RL; Fervenza FC; Kurtin P; Sethi S
J Am Soc Nephrol; 2015 Apr; 26(4):784-90. PubMed ID: 25194005
[TBL] [Abstract][Full Text] [Related]
26. Abnormal immunoglobulin synthesis in monoclonal immunoglobulin light chain and light and heavy chain deposition disease.
Buxbaum JN
Amyloid; 2001 Jun; 8(2):84-93. PubMed ID: 11409038
[TBL] [Abstract][Full Text] [Related]
27. Proliferative glomerulonephritis with discrete deposition of monoclonal immunoglobulin γ1 CH 2 heavy chain and κ light chain: a new variant of monoclonal immunoglobulin deposition disease.
Komatsuda A; Ohtani H; Sawada K; Joh K; Wakui H
Pathol Int; 2013 Jan; 63(1):63-7. PubMed ID: 23356227
[TBL] [Abstract][Full Text] [Related]
28. Renal crescentic alpha heavy chain deposition disease: a report of 3 cases and review of the literature.
Alexander MP; Nasr SH; Watson DC; Méndez GP; Rennke HG
Am J Kidney Dis; 2011 Oct; 58(4):621-5. PubMed ID: 21944962
[TBL] [Abstract][Full Text] [Related]
29. New insights into the pathogenesis and treatment of heavy chain deposition disease.
Hogan JJ; Markowitz GS
Kidney Int; 2017 Feb; 91(2):272-274. PubMed ID: 28087006
[TBL] [Abstract][Full Text] [Related]
30. Light chain nephropathy.
Tubbs RR; Gephardt GN; McMahon JT; Hall PM; Valenzuela R; Vidt DG
Am J Med; 1981 Aug; 71(2):263-9. PubMed ID: 6789678
[TBL] [Abstract][Full Text] [Related]
31. Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft.
Sawada A; Kawanishi K; Horita S; Koike J; Honda K; Ochi A; Komoda M; Tanaka Y; Unagami K; Okumi M; Shimizu T; Ishida H; Tanabe K; Nagashima Y; Nitta K
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():48-52. PubMed ID: 26971743
[TBL] [Abstract][Full Text] [Related]
32. A comparison of several immunochemical approaches for the screening of alpha chain disease.
Orr KB
Diagn Immunol; 1983; 1(1):43-8. PubMed ID: 6437724
[TBL] [Abstract][Full Text] [Related]
33. [Instructions and implementations for percutaneous renal biopsy. Guidelines for the therapy of glomerular nephropaties].
Cagnoli L;
G Ital Nefrol; 2003; 20 Suppl 24():S3-47. PubMed ID: 14666502
[TBL] [Abstract][Full Text] [Related]
34. Single light chain subclass (kappa chain) immunoglobulin deposition in glomerulonephritis.
Alpers CE; Tu WH; Hopper J; Biava CG
Hum Pathol; 1985 Mar; 16(3):294-304. PubMed ID: 3918930
[TBL] [Abstract][Full Text] [Related]
35. Structure of abnormal heavy chains in human heavy-chain-deposition disease.
Khamlichi AA; Aucouturier P; Preud'homme JL; Cogné M
Eur J Biochem; 1995 Apr; 229(1):54-60. PubMed ID: 7744049
[TBL] [Abstract][Full Text] [Related]
36. A case of γ1-heavy chain deposition disease successfully treated with melphalan and prednisolone therapy.
Oe Y; Nakaya I; Yahata M; Sakuma T; Sato H; Soma J
Intern Med; 2010; 49(14):1411-5. PubMed ID: 20647658
[TBL] [Abstract][Full Text] [Related]
37. [A case report of light and heavy chain deposition disease (IgG2 lambda)].
Akashi Y; Yoshizawa N; Oshima S; Takeuchi A; Kubota T; Kondo S; Oshikawa Y; Oda T; Suzuki Y; Shimizu J
Nihon Jinzo Gakkai Shi; 1994 Sep; 36(9):1057-66. PubMed ID: 7967178
[TBL] [Abstract][Full Text] [Related]
38. Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis.
Buxbaum JN; Chuba JV; Hellman GC; Solomon A; Gallo GR
Ann Intern Med; 1990 Mar; 112(6):455-64. PubMed ID: 2106817
[TBL] [Abstract][Full Text] [Related]
39. Nonamyloidotic monoclonal immunoglobulin deposits lack amyloid P component.
Gallo G; Picken M; Frangione B; Buxbaum J
Mod Pathol; 1988 Nov; 1(6):453-6. PubMed ID: 3146753
[TBL] [Abstract][Full Text] [Related]
40. Disappearance of immunoglobulins from persistent renal amyloid deposits following stem cell transplantation for heavy-and light-chain amyloidosis.
Safadi S; Saad A; Quint PS; Sethi S; Leung N; Kurtin P; Nasr SH
Nephrol Dial Transplant; 2015 Jul; 30(7):1151-5. PubMed ID: 25796445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
